These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19523312)

  • 1. Extensively drug-resistant Acinetobacter baumannii.
    Doi Y; Husain S; Potoski BA; McCurry KR; Paterson DL
    Emerg Infect Dis; 2009 Jun; 15(6):980-2. PubMed ID: 19523312
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of combination antibiogram in empirical treatment of infection due to multidrug-resistant Acinetobacter baumannii.
    Apisarnthanarak A; Mundy LM
    Infect Control Hosp Epidemiol; 2008 Jul; 29(7):678-9. PubMed ID: 18624670
    [No Abstract]   [Full Text] [Related]  

  • 3. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.
    Dejsirilert S; Tiengrim S; Sawanpanyalert P; Aswapokee N; Malathum K
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S34-45. PubMed ID: 21294501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overcoming challenges of treating extensively drug-resistant Acinetobacter baumannii bacteraemic urinary tract infection.
    Chuang L; Ratnayake L
    Int J Antimicrob Agents; 2018 Oct; 52(4):521-522. PubMed ID: 30081140
    [No Abstract]   [Full Text] [Related]  

  • 5. OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains.
    Yang Y; Xu Q; Li T; Fu Y; Shi Y; Lan P; Zhao D; Chen Q; Zhou Z; Jiang Y; Peleg AY; Yu Y
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30348663
    [No Abstract]   [Full Text] [Related]  

  • 6. The Brief Case: A Fatal Case of Necrotizing Fasciitis Due to Multidrug-Resistant Acinetobacter baumannii.
    Matthews L; Goodrich JS; Weber DJ; Bergman NH; Miller MB
    J Clin Microbiol; 2019 Jul; 57(7):. PubMed ID: 31239404
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic interactions between colistin and meropenem against extensively drug-resistant and pandrug-resistant Acinetobacter baumannii isolated from ICU patients.
    Vourli S; Frantzeskaki F; Meletiadis J; Stournara L; Armaganidis A; Zerva L; Dimopoulos G
    Int J Antimicrob Agents; 2015 Jun; 45(6):670-1. PubMed ID: 25795317
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro activity of antimicrobial agents against multidrug- and extensively drug-resistant Acinetobacter baumannii.
    Vasconcellos FM; Casas MRT; Tavares LCB; Garcia DO; Camargo CH
    J Med Microbiol; 2017 Jan; 66(1):98-102. PubMed ID: 28056222
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergence of OXA-72-producing Acinetobacter baumannii Belonging to High-Risk Clones (CC15 and CC79) in Different Brazilian States.
    Pagano M; Rocha L; Sampaio JL; Martins AF; Barth AL
    Infect Control Hosp Epidemiol; 2017 Feb; 38(2):252-254. PubMed ID: 27919299
    [No Abstract]   [Full Text] [Related]  

  • 10. Minocycline: an old drug for a new bug: multidrug-resistant Acinetobacter baumannii.
    Goff DA; Kaye KS
    Clin Infect Dis; 2014 Dec; 59 Suppl 6():S365-6. PubMed ID: 25371511
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro activity of tigecycline against multidrug-resistant Acinetobacter baumannii.
    Capone A; D'Arezzo S; Visca P; Petrosillo N;
    J Antimicrob Chemother; 2008 Aug; 62(2):422-3. PubMed ID: 18424790
    [No Abstract]   [Full Text] [Related]  

  • 12. Trend of extensively drug-resistant Acinetobacter baumannii and the remaining therapeutic options: a multicenter study in Tehran, Iran over a 3-year period.
    Jasemi S; Douraghi M; Adibhesami H; Zeraati H; Rahbar M; Boroumand MA; Aliramezani A; Ghourchian S; Mohammadzadeh M
    Lett Appl Microbiol; 2016 Dec; 63(6):466-472. PubMed ID: 27626896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of pan drug-resistant Acinetobacter baumannii in Germany.
    Göttig S; Gruber TM; Higgins PG; Wachsmuth M; Seifert H; Kempf VA
    J Antimicrob Chemother; 2014 Sep; 69(9):2578-9. PubMed ID: 24833751
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative in vitro activities of tigecycline and 11 other antimicrobial agents against 215 epidemiologically defined multidrug-resistant Acinetobacter baumannii isolates.
    Seifert H; Stefanik D; Wisplinghoff H
    J Antimicrob Chemother; 2006 Nov; 58(5):1099-100. PubMed ID: 16980293
    [No Abstract]   [Full Text] [Related]  

  • 15. High mortality rates among solid organ transplant recipients infected with extensively drug-resistant Acinetobacter baumannii: using in vitro antibiotic combination testing to identify the combination of a carbapenem and colistin as an effective treatment regimen.
    Shields RK; Kwak EJ; Potoski BA; Doi Y; Adams-Haduch JM; Silviera FP; Toyoda Y; Pilewski JM; Crespo M; Pasculle AW; Clancy CJ; Nguyen MH
    Diagn Microbiol Infect Dis; 2011 Jun; 70(2):246-52. PubMed ID: 21353436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case Report of Successful Treatment of Extensively Drug-Resistant Acinetobacter baumannii Ventriculitis with Intravenous plus Intraventricular Tigecycline.
    Liu Y; Pu Z; Zhao M
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104281
    [No Abstract]   [Full Text] [Related]  

  • 17. Confronting multidrug-resistant Acinetobacter baumannii: a review.
    Neonakis IK; Spandidos DA; Petinaki E
    Int J Antimicrob Agents; 2011 Feb; 37(2):102-9. PubMed ID: 21130607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistant and extensively drug resistant Acinetobacter baumannii hospital infection associated with high mortality: a retrospective study in the pediatric intensive care unit.
    Shi J; Sun T; Cui Y; Wang C; Wang F; Zhou Y; Miao H; Shan Y; Zhang Y
    BMC Infect Dis; 2020 Aug; 20(1):597. PubMed ID: 32787942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acinetobacter baumannii resistant to everything: what should we do?
    Vila J; Pachón J
    Clin Microbiol Infect; 2011 Jul; 17(7):955-6. PubMed ID: 21722248
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergence of an extreme-drug-resistant (XDR) Acinetobacter baumannii carrying blaOXA-23 in a patient with acute necrohaemorrhagic pancreatitis.
    Grosso F; Quinteira S; Peixe L
    J Hosp Infect; 2010 May; 75(1):82-3. PubMed ID: 20303617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.